18
Views
4
CrossRef citations to date
0
Altmetric
Review

Should microchimerism turn into rejection prophylactics?

Pages 107-118 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Ghasem Solgi, Vijayakrishna Gadi, Biswajit Paul, Joannis Mytilineos, Gholamreza Pourmand, Abdolrasoul Mehrsai, Moslem Ranjbar, Mousa Mohammadnia, Behrouz Nikbin & Ali Akbar Amirzargar. (2013) Five-year clinical effects of donor bone marrow cells infusions in kidney allograft recipients. Chimerism 4:3, pages 87-94.
Read now
Josep-Maria Pujal, Santiago Roura, Ana M. Muñoz-Marmol, Jose-Luis Mate & Antoni Bayes-Genis. (2012) Fetal-maternal interface: A chronicle of allogeneic coexistence. Chimerism 3:1, pages 18-23.
Read now
Ghasem Solgi, Joannis Mytilineos, Vijayakrishna K. Gadi, Biswajit Paul, Gholamreza Pourmand, Abdolrasoul Mehrsai, Behrouz Nikbin & Ali Akbar Amirzargar. (2011) Donor-derived peripheral mononuclear cell DNA is associated with stable kidney allograft function: A randomized controlled trial. Chimerism 2:4, pages 102-110.
Read now

Articles from other publishers (1)

Santiago Roura, Josep-Maria Pujal, Carolina Gálvez-Montón & Antoni Bayes-Genis. (2015) The role and potential of umbilical cord blood in an era of new therapies: a review. Stem Cell Research & Therapy 6:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.